Corient Capital Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.12M | Hold |
1,896
| – | – | 0.08% | 200 |
|
|
2022
Q2 | $1.12M | Buy |
1,896
+31
| +2% | +$18.3K | 0.09% | 203 |
|
|
2022
Q1 | $1.3M | Buy |
1,865
+479
| +35% | +$335K | 0.09% | 206 |
|
|
2021
Q4 | $875K | Buy |
1,386
+41
| +3% | +$25.9K | 0.06% | 245 |
|
|
2021
Q3 | $814K | Sell |
1,345
-212
| -14% | -$128K | 0.06% | 249 |
|
|
2021
Q2 | $870K | Buy |
1,557
+180
| +13% | +$101K | 0.06% | 233 |
|
|
2021
Q1 | $652K | Buy |
1,377
+35
| +3% | +$16.6K | 0.06% | 267 |
|
|
2020
Q4 | $649K | Sell |
1,342
-409
| -23% | -$198K | 0.06% | 234 |
|
|
2020
Q3 | $980K | Sell |
1,751
-105
| -6% | -$58.8K | 0.11% | 167 |
|
|
2020
Q2 | $1.16M | Buy |
1,856
+729
| +65% | +$455K | 0.14% | 136 |
|
|
2020
Q1 | $550K | Buy |
1,127
+217
| +24% | +$106K | 0.09% | 201 |
|
|
2019
Q4 | $342K | Buy |
+910
| New | +$342K | 0.04% | 332 |
|